Collectively, these results demonstrate that GJB2 and SCN9A promote GBM growth in vitro and in vivo, are consistent with the findings that GBM-relevant genes and pathways are altered by their deficiency (Fig. 4) and establish GJB2 and SCN9A as functional regulators of GBM aggression. This evidence concerns the gene SCN9A and glioblastoma.